Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide for Prevention of Postoperative Pancreatic Fistula
NCT03174353Phase 2Completed
- Sponsor
- University of Washington
- Start
- Feb 2018
- Primary completion
- Feb 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of lanreotide in pancreatic fistula (POPF), sponsored by University of Washington. Started Feb 2018; status: completed.
02
Drugs
lanreotide
03
Conditions
pancreatic fistula (POPF)
Beyond the preview
Go deeper on NCT03174353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03174353.